Tizan
Tizan is a muscle relaxant containing Tizanidine. It is a short-acting drug used to manage increased muscle tone, cramping, and tightness associated with spasticity. It acts as an agonist at central alpha-2 adrenergic receptor sites, reducing spasticity by increasing presynaptic inhibition of motor neurons.
Dosage by Body Weight
Adult dosage usually begins at 2 mg to 4 mg orally every 6 to 8 hours as needed, up to a maximum of 36 mg per day. Dose titration should be gradual. Avoid abrupt discontinuation. Not recommended for pediatric use.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Not routine
- Tracking Notes
- Safety and effectiveness of Tizanidine in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Not routine
- Tracking Notes
- Safety and effectiveness of Tizanidine in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Not routine
- Tracking Notes
- Safety and effectiveness of Tizanidine in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Not routine
- Tracking Notes
- Safety and effectiveness of Tizanidine in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Not routine
- Tracking Notes
- Safety and effectiveness of Tizanidine in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Not routine | Safety and effectiveness of Tizanidine in pediatric patients have not been established. |
| 5-7 kg | Not recommended | Not routine | Safety and effectiveness of Tizanidine in pediatric patients have not been established. |
| 8-10 kg | Not recommended | Not routine | Safety and effectiveness of Tizanidine in pediatric patients have not been established. |
| 11-15 kg | Not recommended | Not routine | Safety and effectiveness of Tizanidine in pediatric patients have not been established. |
| 16-20 kg | Not recommended | Not routine | Safety and effectiveness of Tizanidine in pediatric patients have not been established. |
Formulation
Purpose
Relief of muscle spasms and spasticity associated with neurological conditions (such as multiple sclerosis and spinal cord injury) and painful musculoskeletal conditions.
Generic Name
TizanidineScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.